D'Souza Karen M, Petrashevskaya Natalia N, Merrill Walter H, Akhter Shahab A
Department of Surgery, Section of Cardiothoracic Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
J Thorac Cardiovasc Surg. 2008 Jan;135(1):172-9, 179.e1. doi: 10.1016/j.jtcvs.2007.08.035.
The specific effect of protein kinase C alpha, the primary ventricular calcium-dependent protein kinase C isoform, on myocardial protection is unclear. The objective of this study was to determine the role of protein kinase C alpha in myocardial protection and recovery of function after cardioplegic arrest, cold preservation, and normothermic reperfusion, as relevant to cardiac transplantation.
We used an ex vivo murine model, and hearts were arrested with cold crystalloid cardioplegia or saline as a control and maintained at 4 degrees C for 4 hours. This was followed by normothermic reperfusion for 90 minutes. Transgenic hearts with cardiac-specific activation or inhibition of protein kinase C alpha were then studied to specifically examine the effects of protein kinase C alpha on myocardial preservation in this model.
Cardioplegic arrest with University of Wisconsin solution led to significantly improved postreperfusion hemodynamics and inhibition of myocardial protein kinase C alpha activity relative to that seen in saline-treated control hearts. Beta-adrenergic receptor signaling was also preserved with University of Wisconsin solution. Transgenic hearts with enhanced protein kinase C alpha activity had poor postreperfusion hemodynamics, impaired beta-adrenergic receptor signaling, and increased G protein-coupled receptor kinase 2 activity compared with those seen in nontransgenic control hearts. In contrast, transgenic hearts with inhibited protein kinase C alpha activity had even better myocardial protection relative to control hearts and preserved beta-adrenergic receptor signaling.
Current techniques of myocardial preservation are associated with inhibition of protein kinase C alpha activity and maintenance of intact beta-adrenergic receptor signaling. Activation of protein kinase C alpha leads to enhanced beta-adrenergic receptor desensitization and impaired signaling and ventricular function as a result of increased G protein-coupled receptor kinase 2 activity. This is a novel in vivo mechanism of G protein-coupled receptor kinase 2 activation. Strategies to specifically inhibit these kinases might improve long-term myocardial protection.
蛋白激酶Cα是心室主要的钙依赖性蛋白激酶C亚型,其对心肌保护的具体作用尚不清楚。本研究的目的是确定蛋白激酶Cα在心脏停搏、冷保存和常温再灌注后心肌保护及功能恢复中的作用,这与心脏移植相关。
我们使用了一种离体小鼠模型,心脏用冷晶体心脏停搏液停搏或用生理盐水作为对照,在4℃下维持4小时。随后进行90分钟的常温再灌注。然后研究具有心脏特异性激活或抑制蛋白激酶Cα的转基因心脏,以具体检查蛋白激酶Cα在该模型中对心肌保存的影响。
与生理盐水处理的对照心脏相比,用威斯康星大学溶液进行心脏停搏导致再灌注后血流动力学显著改善,心肌蛋白激酶Cα活性受到抑制。威斯康星大学溶液还能保留β-肾上腺素能受体信号传导。与非转基因对照心脏相比,蛋白激酶Cα活性增强的转基因心脏再灌注后血流动力学较差,β-肾上腺素能受体信号传导受损,G蛋白偶联受体激酶2活性增加。相比之下,蛋白激酶Cα活性受到抑制的转基因心脏相对于对照心脏具有更好的心肌保护作用,并保留了β-肾上腺素能受体信号传导。
目前的心肌保存技术与蛋白激酶Cα活性的抑制和完整的β-肾上腺素能受体信号传导的维持有关。蛋白激酶Cα的激活导致β-肾上腺素能受体脱敏增强、信号传导受损和心室功能受损,这是由于G蛋白偶联受体激酶2活性增加所致。这是G蛋白偶联受体激酶2激活的一种新的体内机制。特异性抑制这些激酶的策略可能会改善长期心肌保护。